- Filed
- Feb 21, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Feb 16, 2024 | 36.41M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2023 | 36.38M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2023 | 34.92M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 31.51M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 31.5M sh |
| Capex | Q2 2024 · Dec 31, 2023 | $2.66M |
| Capex | Q2 2024 · Dec 31, 2022 | $10.7M |
| Operating Cash Flow | Q2 2024 · Dec 31, 2023 | −$10.79M |
| Operating Cash Flow | Q2 2024 · Dec 31, 2022 | −$11.78M |
| Long Term Debt | Q2 2024 · Dec 31, 2023 | $23.6M |
| Long Term Debt | Q2 2024 · Mar 31, 2023 | $26.28M |
| Short Term Debt | Q2 2024 · Dec 31, 2023 | $1.8M |
| Short Term Debt | Q2 2024 · Mar 31, 2023 | $1.64M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $15.94M |
| Cash And Equivalents | Q2 2024 · Mar 31, 2023 | $17.36M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2022 | $15.53M |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | $14.16M |
| Stockholders Equity | Q2 2024 · Sep 30, 2023 | $47.12M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $59.07M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $61.3M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $82.99M |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | $91.62M |
| Stockholders Equity | Q2 2024 · Jun 30, 2022 | $104.85M |
| Stockholders Equity | Q2 2024 · Mar 31, 2022 | $164.05M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $82.11M |
| Current Liabilities | Q2 2024 · Mar 31, 2023 | $54.04M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $125.96M |
| Total Liabilities | Q2 2024 · Mar 31, 2023 | $102.23M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $114.01M |
| Current Assets | Q2 2024 · Mar 31, 2023 | $96.22M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $140.12M |
| Total Assets | Q2 2024 · Mar 31, 2023 | $163.53M |
| Eps Diluted | Q2 2024 · Dec 31, 2023 | −$0.94 |
| Eps Diluted | Q2 2024 · Dec 31, 2023 | −$1.48 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | −$0.35 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | −$2.68 |
| Eps Basic | Q2 2024 · Dec 31, 2023 | −$0.94 |
| Eps Basic | Q2 2024 · Dec 31, 2023 | −$1.48 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | −$0.35 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | −$2.68 |
| Sga Expense | Q2 2024 · Dec 31, 2023 | $9.38M |
| Sga Expense | Q2 2024 · Dec 31, 2023 | $27.26M |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $10.86M |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $34.32M |
| Rd Expense | Q2 2024 · Dec 31, 2023 | $4.05M |
| Rd Expense | Q2 2024 · Dec 31, 2023 | $11.73M |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $5.09M |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $16.32M |
| Net Income | Q2 2024 · Dec 31, 2023 | −$34.34M |
| Net Income | Q2 2024 · Dec 31, 2023 | −$51.81M |
| Net Income | Q2 2024 · Sep 30, 2023 | −$12.54M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$4.92M |
| Net Income | Q2 2024 · Dec 31, 2022 | −$11.08M |
| Net Income | Q2 2024 · Dec 31, 2022 | −$84.46M |
| Net Income | Q2 2024 · Sep 30, 2022 | −$13.2M |
| Net Income | Q2 2024 · Jun 30, 2022 | −$60.18M |
| Operating Income | Q2 2024 · Dec 31, 2023 | −$32.82M |
| Operating Income | Q2 2024 · Dec 31, 2023 | −$54.56M |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$10.29M |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$75.81M |
| Gross Profit | Q2 2024 · Dec 31, 2023 | $17.39M |
| Gross Profit | Q2 2024 · Dec 31, 2023 | $35.99M |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $22.86M |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $41.28M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2023 | $50.18M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2023 | $121.98M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $75.22M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $177.08M |
| Revenue | Q2 2024 · Dec 31, 2023 | $67.57M |
| Revenue | Q2 2024 · Dec 31, 2023 | $157.98M |
| Revenue | Q2 2024 · Dec 31, 2022 | $98.08M |
| Revenue | Q2 2024 · Dec 31, 2022 | $218.35M |
| Stock Issued | Q2 2024 · Jul 28, 2023 | 573.36K sh |